These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 14686702

  • 1. Chemoprevention of superficial bladder cancer.
    Kamat AM.
    Expert Rev Anticancer Ther; 2003 Dec; 3(6):799-808. PubMed ID: 14686702
    [Abstract] [Full Text] [Related]

  • 2. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
    García Rodríguez J, Fernández Gómez JM, Escaf Barmadah S, González Alvarez RC, Jalón Monzón A, Martínez Gómez FJ, Sánchez Trilla A, Regadera Sejas J.
    Arch Esp Urol; 2007 Dec; 60(1):36-43. PubMed ID: 17408170
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Adjuvant intravesical treatment with a standardized mistletoe extract to prevent recurrence of superficial urinary bladder cancer.
    Elsässer-Beile U, Leiber C, Wetterauer U, Bühler P, Wolf P, Lucht M, Mengs U.
    Anticancer Res; 2005 Dec; 25(6C):4733-6. PubMed ID: 16334168
    [Abstract] [Full Text] [Related]

  • 5. Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer.
    Messing E, Kim KM, Sharkey F, Schultz M, Parnes H, Kim D, Saltzstein D, Wilding G.
    J Urol; 2006 Aug; 176(2):500-4. PubMed ID: 16813878
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30mg/40ml, 40mg/40ml.
    Kuroda M, Niijima T, Kotake T, Akaza H, Hinotsu S, 6th Trial of the Japanese Urological Cancer Research Group.
    Eur Urol; 2004 May; 45(5):600-5. PubMed ID: 15082202
    [Abstract] [Full Text] [Related]

  • 9. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
    Gofrit ON, Shapiro A, Pode D, Sidi A, Nativ O, Leib Z, Witjes JA, van der Heijden AG, Naspro R, Colombo R.
    Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
    Yumura Y, Oogo Y, Takase K, Hamano A, Yamashita Y, Noguchi S, Satomi Y.
    Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Intravesical chemotherapy for carcinoma of the bladder--duration of the treatment course.
    Jakse G.
    Prog Clin Biol Res; 1985 Nov; 185B():69-78. PubMed ID: 3898142
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Directed chemotherapy in superficial carcinoma conditioned by the knowledge of relapse factors].
    Oliver F, Llopis B, Vera C, Domínguez C, Vidal J, Gallego J, Jiménez JF.
    Actas Urol Esp; 1988 Nov; 12(5):419-23. PubMed ID: 3218579
    [No Abstract] [Full Text] [Related]

  • 18. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
    Han RF, Pan JG.
    Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182
    [Abstract] [Full Text] [Related]

  • 19. Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    Parekh DJ, Bochner BH, Dalbagni G.
    J Clin Oncol; 2006 Dec 10; 24(35):5519-27. PubMed ID: 17158537
    [Abstract] [Full Text] [Related]

  • 20. [Intravesial instillation of recombination interferon-alpha and pirarubicin in the prophylaxis of local recurrence after resection of the superficial bladder cancer].
    Deng JH, Bai JL, Zhang SS, Ma PC, Wan JH.
    Ai Zheng; 2004 Jul 10; 23(7):839-41. PubMed ID: 15248924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.